Compare CSX Corporation (CSX) vs Hims and Hers Health Inc (HIMS) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
CSX Corporation vs Hims and Hers Health Inc — how do they compare? CSX Corporation trades at $47.26 (market cap $87.70B), while Hims and Hers Health Inc trades at $30.92 (market cap $6.55B). The key difference: CSX Corporation is far larger — about 13.4× Hims and Hers Health Inc's market cap, and CSX Corporation pays a 1.18% dividend while Hims and Hers Health Inc pays none. Which is the better fit depends on your goals — on Pluang, investors hold CSX Corporation for 55 Days and Hims and Hers Health Inc for 21 Days on average.
| CSX | HIMS | |
|---|---|---|
Market Cap | $87.70B | $6.55B |
Volume | 6,980,781 | 14,842,814 |
Sector | Industrials | Health |
52-Week High | $53.21 | $62.76 |
52-Week Low | $33.68 | $14.52 |
Typical Hold Time | 55 Days | 21 Days |
Enterprise Value | $105.66B | $7.25B |
Dividend Yield | 1.18% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
CSX trades at $47.34, up 1.13% today, with a bullish technical signal and strong institutional interest. Recent earnings show a beat in Q1 and Q2 2026, though Q4 2025 missed expectations. Revenue has declined from $14.9B in 2022 to $14.1B in 2025, with net income falling to $2.89B. The company maintains solid profitability with a 22.21% net margin and 24.37% ROE, but valuation ratios like P/E of 27.52 and P/S of 6.08 appear elevated. A dividend of $0.14 is scheduled for payment in September 2026.
The outlook for CSX is cautiously optimistic, supported by analyst consensus with a $51 price target and 58.69% buy ratings. Key opportunities include pricing power in freight rail and expected earnings recovery in 2026. Risks involve revenue declines, high debt levels, and sensitivity to economic cycles. The stock's current technical strength and institutional accumulation suggest potential upside if operational trends improve.
HIMS stock trades at $28.06, down 5.01% on the day, amid a bearish technical signal and negative earnings surprises. The company reported a net loss of $142 million in 2026, with a negative net income margin of -5.51%, despite revenue growth to $2.6 billion. Multiple securities class action lawsuits filed in October 2026 create significant legal overhang, while analyst consensus remains mixed with a $32.17 price target but only 35% buy ratings.
The outlook is clouded by profitability challenges and legal risks, though revenue growth offers a potential catalyst if margins improve. Investors face substantial downside risk from ongoing litigation and weak earnings, offset by analyst price targets suggesting modest upside from current levels if operational execution improves.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About CSX Corporation
Operating in the Eastern United States, Class I railroad CSX generated revenue near $12.5 billion in 2021. On its more than 21,000 miles of track, CSX hauls shipments of coal (13% of consolidated revenue), chemicals (22%), intermodal containers (16%), automotive cargo (9%), and a diverse mix of other bulk and industrial merchandise.
Read more on CSX →About Hims and Hers Health Inc
Hims & Hers is a multi-specialty telehealth platform that provides personalized health and wellness products. It offers access to medical providers and treatments for hair loss, sexual health, and skincare.
Read more on HIMS →
